137 related articles for article (PubMed ID: 18083835)
1. Proteasomal degradation of human release factor eRF3a regulates translation termination complex formation.
Chauvin C; Jean-Jean O
RNA; 2008 Feb; 14(2):240-5. PubMed ID: 18083835
[TBL] [Abstract][Full Text] [Related]
2. Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation.
Chauvin C; Salhi S; Le Goff C; Viranaicken W; Diop D; Jean-Jean O
Mol Cell Biol; 2005 Jul; 25(14):5801-11. PubMed ID: 15987998
[TBL] [Abstract][Full Text] [Related]
3. PABP enhances release factor recruitment and stop codon recognition during translation termination.
Ivanov A; Mikhailova T; Eliseev B; Yeramala L; Sokolova E; Susorov D; Shuvalov A; Schaffitzel C; Alkalaeva E
Nucleic Acids Res; 2016 Sep; 44(16):7766-76. PubMed ID: 27418677
[TBL] [Abstract][Full Text] [Related]
4. Human eukaryotic release factor 3a depletion causes cell cycle arrest at G1 phase through inhibition of the mTOR pathway.
Chauvin C; Salhi S; Jean-Jean O
Mol Cell Biol; 2007 Aug; 27(16):5619-29. PubMed ID: 17562865
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies against human translation termination factor eRF3 and their utilization for sub-cellular localization of eRF3.
Delage MM; Dutertre S; Le Guével R; Frolova L; Berkova N
J Biochem; 2011 Jul; 150(1):49-59. PubMed ID: 21421683
[TBL] [Abstract][Full Text] [Related]
6. C-terminal domains of human translation termination factors eRF1 and eRF3 mediate their in vivo interaction.
Merkulova TI; Frolova LY; Lazar M; Camonis J; Kisselev LL
FEBS Lett; 1999 Jan; 443(1):41-7. PubMed ID: 9928949
[TBL] [Abstract][Full Text] [Related]
7. The stretch of C-terminal acidic amino acids of translational release factor eRF1 is a primary binding site for eRF3 of fission yeast.
Ito K; Ebihara K; Nakamura Y
RNA; 1998 Aug; 4(8):958-72. PubMed ID: 9701287
[TBL] [Abstract][Full Text] [Related]
8. Termination of translation in eukaryotes is mediated by the quaternary eRF1*eRF3*GTP*Mg2+ complex. The biological roles of eRF3 and prokaryotic RF3 are profoundly distinct.
Mitkevich VA; Kononenko AV; Petrushanko IY; Yanvarev DV; Makarov AA; Kisselev LL
Nucleic Acids Res; 2006; 34(14):3947-54. PubMed ID: 16914449
[TBL] [Abstract][Full Text] [Related]
9. Translation termination in eukaryotes: polypeptide release factor eRF1 is composed of functionally and structurally distinct domains.
Frolova LY; Merkulova TI; Kisselev LL
RNA; 2000 Mar; 6(3):381-90. PubMed ID: 10744022
[TBL] [Abstract][Full Text] [Related]
10. Evolution of translation termination factor eRF3: is GSPT2 generated by retrotransposition of GSPT1's mRNA?
Zhouravleva G; Schepachev V; Petrova A; Tarasov O; Inge-Vechtomov S
IUBMB Life; 2006 Apr; 58(4):199-202. PubMed ID: 16754297
[TBL] [Abstract][Full Text] [Related]
11. GTP hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination.
Salas-Marco J; Bedwell DM
Mol Cell Biol; 2004 Sep; 24(17):7769-78. PubMed ID: 15314182
[TBL] [Abstract][Full Text] [Related]
12. eRF3a/GSPT1 12-GGC allele increases the susceptibility for breast cancer development.
Malta-Vacas J; Chauvin C; Gonçalves L; Nazaré A; Carvalho C; Monteiro C; Bagrel D; Jean-Jean O; Brito M
Oncol Rep; 2009 Jun; 21(6):1551-8. PubMed ID: 19424636
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic polypeptide chain release factor eRF3 is an eRF1- and ribosome-dependent guanosine triphosphatase.
Frolova L; Le Goff X; Zhouravleva G; Davydova E; Philippe M; Kisselev L
RNA; 1996 Apr; 2(4):334-41. PubMed ID: 8634914
[TBL] [Abstract][Full Text] [Related]
14. Chemical footprinting reveals conformational changes of 18S and 28S rRNAs at different steps of translation termination on the human ribosome.
Bulygin KN; Bartuli YS; Malygin AA; Graifer DM; Frolova LY; Karpova GG
RNA; 2016 Feb; 22(2):278-89. PubMed ID: 26655225
[TBL] [Abstract][Full Text] [Related]
15. Studies on human eRF3-PABP interaction reveal the influence of eRF3a N-terminal glycin repeat on eRF3-PABP binding affinity and the lower affinity of eRF3a 12-GGC allele involved in cancer susceptibility.
Jerbi S; Jolles B; Bouceba T; Jean-Jean O
RNA Biol; 2016; 13(3):306-15. PubMed ID: 26818177
[TBL] [Abstract][Full Text] [Related]
16. [Identification of a novel termination release factor eRF3b expressing the eRF3 activity in vitro and in vivo].
Jakobsen CG; Segaard TM; Jean-Jean O; Frolova L; Justesen J
Mol Biol (Mosk); 2001; 35(4):672-81. PubMed ID: 11524954
[TBL] [Abstract][Full Text] [Related]
17. Suppression of eukaryotic translation termination by selected RNAs.
Carnes J; Frolova L; Zinnen S; Drugeon G; Phillippe M; Justesen J; Haenni AL; Leinwand L; Kisselev LL; Yarus M
RNA; 2000 Oct; 6(10):1468-79. PubMed ID: 11073222
[TBL] [Abstract][Full Text] [Related]
18. Effect of small molecule eRF3 degraders on premature termination codon readthrough.
Baradaran-Heravi A; Balgi AD; Hosseini-Farahabadi S; Choi K; Has C; Roberge M
Nucleic Acids Res; 2021 Apr; 49(7):3692-3708. PubMed ID: 33764477
[TBL] [Abstract][Full Text] [Related]
19. Exploring contacts of eRF1 with the 3'-terminus of the P site tRNA and mRNA stop signal in the human ribosome at various translation termination steps.
Bulygin KN; Graifer DM; Hountondji C; Frolova LY; Karpova GG
Biochim Biophys Acta Gene Regul Mech; 2017 Jul; 1860(7):782-793. PubMed ID: 28457996
[TBL] [Abstract][Full Text] [Related]
20. Translation termination: new factors and insights.
Baierlein C; Krebber H
RNA Biol; 2010; 7(5):548-50. PubMed ID: 21081843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
